THE HEPARIN TRAGEDY
In 2007/8, pharmaceutical supply chains became the subject of global debate among key stakeholders, but for the wrong reasons.
A tragic event occurred that shocked the world into realizing that pharmaceutical supply chains had the potential to kill and maim unsuspecting patients.
A blood thinning agent, heparin, had been adulterated […
Keep reading with a 7-day free trial
Subscribe to INSIDE PHARMA to keep reading this post and get 7 days of free access to the full post archives.